Control impurity risks at trace levels
Trace impurities, whether elemental, organic, or process-related, can pose significant regulatory and patient safety risks if not properly understood and controlled. Our impurities testing services provide the sensitive, GMP-compliant data needed to demonstrate control across raw materials, in-process formulations, and finished products.
Backed by experienced analytical scientists and robust quality systems, we support impurity programs aligned with evolving regulatory expectations. From routine monitoring to complex investigations, our teams apply advanced instrumentation, validated methodologies, and practical regulatory insight to help you mitigate risk, support submissions, and maintain confidence throughout the product lifecycle.
Our impurities testing services include:
- Elemental impurities testing: Trace metals analysis aligned with USP <232>, USP <233>, EP 5.20, and EP 2.4.20 requirements.
- Nitrosamine impurities testing: Sensitive testing to detect and quantify nitrosamine impurities and support regulatory risk mitigation strategies.
- Residual solvent testing: Identification and quantitation of residual solvents to demonstrate process control and product safety.
- Raw materials and finished goods support: Testing across APIs, excipients, in-process materials, and finished pharmaceutical products.
- Container closure systems and manufacturing: Extractables and leachables with USP <1663>, USP <1664>, USP <665>, and USP <1665>.
- Method development and validation: Custom, phase-appropriate methods to address novel products, evolving guidance, or unique matrices.